Univercells Technologies Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 68

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Univercells Technologies General Information

Description

Manufacturer of bioprocess technologies intended for the production of viral vaccines and viral vectors. The company provides intensified fixed-bed bioreactors and automated upstream platforms, enabling cell and gene therapy manufacturers to achieve cost-effective and scalable manufacturing of high-quality therapies with a reduced footprint.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Avenue Herrmann-Debroux 54
  • Chemin de la Vieille Cour 56a & 56b
  • 1400 Nivelles
  • Belgium
+32 02
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Parent Company
Vertical(s)
Corporate Office
  • Avenue Herrmann-Debroux 54
  • Chemin de la Vieille Cour 56a & 56b
  • 1400 Nivelles
  • Belgium
+32 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Univercells Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Univercells Technologies‘s full profile, request access.

Request a free trial

Univercells Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of bioprocess technologies intended for the production of viral vaccines and viral vectors. The company pro
Biotechnology
Nivelles, Belgium
68 As of 2026

San Francisco, CA
 

Zurich, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Univercells Technologies Competitors (13)

One of Univercells Technologies’s 13 competitors is Vir Biotechnology, a Formerly VC-backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vir Biotechnology Formerly VC-backed San Francisco, CA
Araris Formerly VC-backed Zurich, Switzerland
Diagenode Formerly VC-backed Seraing, Belgium
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD
Complete Genomics Formerly VC-backed San Jose, CA
You’re viewing 5 of 13 competitors. Get the full list »

Univercells Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Univercells Technologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Univercells Technologies‘s full profile, request access.

Request a free trial

Univercells Technologies FAQs

  • When was Univercells Technologies founded?

    Univercells Technologies was founded in 2013.

  • Where is Univercells Technologies headquartered?

    Univercells Technologies is headquartered in Nivelles, Belgium.

  • What is the size of Univercells Technologies?

    Univercells Technologies has 68 total employees.

  • What industry is Univercells Technologies in?

    Univercells Technologies’s primary industry is Biotechnology.

  • Is Univercells Technologies a private or public company?

    Univercells Technologies is a Private company.

  • What is the current valuation of Univercells Technologies?

    The current valuation of Univercells Technologies is .

  • What is Univercells Technologies’s current revenue?

    The current revenue for Univercells Technologies is .

  • How much funding has Univercells Technologies raised over time?

    Univercells Technologies has raised $53.1M.

  • Who are Univercells Technologies’s investors?

    Gamma Biosciences and Univercells have invested in Univercells Technologies.

  • Who are Univercells Technologies’s competitors?

    Vir Biotechnology, Araris, Diagenode, Personal Genome Diagnostics, and Complete Genomics are some of the 13 competitors of Univercells Technologies.

  • When was Univercells Technologies acquired?

    Univercells Technologies was acquired on 29-Jun-2023.

  • Who acquired Univercells Technologies?

    Univercells Technologies was acquired by Donaldson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process